Furthermore, a single injection of anti-TNF-α mAb and two injections (on days 8 and 12, or days 12 and 16) of CTLA-4Ig markedly reduced the severity of the disease.
At days 8 and 9, GSC extract (500 mg/kg/day) markedly reduced the severity of DSS-induced acute colitis symptoms as evidenced by the decrease of weight loss (* P < 0.01 versus DSS)).
In apolipoprotein E-deficient mice fed with a high-lipid diet, an experimental model of atherosclerosis, IL-33, markedly reduced the severity of aortic lesions via induction of Th2 responses such as IL-5.
In a total of three experiments, intraperitoneal administration of K1 5 at a dose of 2 mg/kg (40 μg per mouse) every day until day 10 markedly reduced the severity of CIA.
Using the K/BxN mouse model, a separate study show reduced disease development in PI3Kβ deficient mice at low, but not high doses of serum transfer, while additional PI3Kδ deficiency markedly reduced disease severity at high serum transfer doses, indicating a role for dual PI3Kδ/PI3Kβ inhibitors in this context [ 7].
In addition, injection of 50 pg capped npnt mRNA markedly reduced the severity of the AV canal defect in the remaining embryos, with defective hearts showing an increase in type I defects (from 23.6±1.2%too 48.7±2.4%) and a decrease in type II defects (from 60±1.1% to 26.5±2.6%) (Fig. 3G).
Furthermore, we have shown for the first time that inhibition of the angiopoietin Tie axis can markedly reduce arthritis severity.
In this study, we demonstrate that using a self-help book to deliver a CBT-treatment can markedly reduce insomnia severity, and improve sleep and day-time functioning, in adults with insomnia and co-morbid problems.
The present study shows that unique ASV derived from receptors that play key roles in angiogenesis – namely, VEGF receptor type 1 and, for the first time, Tie1 – can markedly reduce arthritis severity.
Subcutaneous treatment with the CCR5 antagonist initiated a few days before clinical signs of arthritis developed markedly reduced the incidence and severity of the disease, in association with significantly decreased leucocyte migration to the joints.
Disease severity was markedly reduced by PPI-2458.
